MedTrace Logo

Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease

NCT00755690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-02-19

No results posted yet for this study

Summary

This study is designed to describe the physiological response to increased and decreased dietary phosphate intake on various parameters of mineral metabolism in the blood and urine of individuals with Chronic Kidney Disease stage 3 and 4 with normal serum phosphate levels. This detailed study will give us a far greater understanding of the role of diet in abnormal mineral homeostasis early in the progression of this chronic disease. The findings of this study will help both physicians and dietitians better determine the optimal time to introduce dietary therapy in CKD.

Conditions

Interventions

BEHAVIORAL

High/ Low Phosphate diet

Low phosphate diet (750mg/day).

BEHAVIORAL

High/ Low Phosphate diet

Low phosphate diet (750mg/day) with the addition of the phosphate binder aluminum hydroxide (500mg three times per day).

BEHAVIORAL

High/ Low Phosphate diet

III. High phosphate diet (2000mg /day).

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Adeera Levin, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755690 on ClinicalTrials.gov